COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 38 filers reported holding COMPASS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $230,258 | -38.1% | 116,882 | 0.0% | 0.07% | -29.4% |
| Q2 2023 | $371,685 | -2.8% | 116,882 | 0.0% | 0.10% | -11.3% |
| Q1 2023 | $382,204 | -87.4% | 116,882 | -80.6% | 0.12% | -86.5% |
| Q4 2022 | $3,028,316 | +605.9% | 602,051 | +220.1% | 0.85% | +641.7% |
| Q3 2022 | $429,000 | -18.3% | 188,094 | -5.0% | 0.12% | -19.6% |
| Q2 2022 | $525,000 | +95.2% | 198,094 | +1.0% | 0.14% | +104.3% |
| Q1 2022 | $269,000 | -56.8% | 196,091 | 0.0% | 0.07% | -55.1% |
| Q4 2021 | $622,000 | – | 196,091 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,500,000 | $11,165,000 | 7.28% |
| Foresite Capital Management V, LLC | 4,400,000 | $13,948,000 | 3.43% |
| CHI Advisors LLC | 3,023,692 | $9,585,000 | 3.18% |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $3,487,000 | 2.34% |
| Monashee Investment Management LLC | 2,000,000 | $6,340,000 | 1.57% |
| Orbimed Advisors | 21,642,975 | $68,608,000 | 0.88% |
| Rock Springs Capital Management LP | 5,328,088 | $16,890,000 | 0.39% |
| Vivo Capital, LLC | 2,000,000 | $6,340,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,000 | $2,219,000 | 0.24% |
| DAFNA Capital Management LLC | 196,091 | $622,000 | 0.16% |